STOCK TITAN

Precigen COO sells 50K shares after option exercise

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PRECIGEN, INC. (PGEN) reported that Chief Operating Officer Rutul R. Shah exercised stock options and RSUs and sold common shares. On August 21 and 25, 2026, he exercised options for a total of 50,000 shares at $2.33 per share and sold 50,000 shares at $7.50 per share pursuant to a Rule 10b5-1 trading plan. On August 23, 2026, 7,500 RSUs converted into common stock, and 3,647 shares were withheld to satisfy tax obligations, leaving 57,292 RSUs outstanding.

Positive

  • None.

Negative

  • None.
Insider Shah Rutul R
Role Chief Operating Officer
Sold 50,000 shs ($375K)
Approx. gross sale proceeds $375K
Type Security Shares Price Value
Exercise Option to Purchase Common Stock (Right to Buy) F4 15,342 $0.00 $0.00
Exercise Common Stock 15,342 $2.33 $36K
Sale Common Stock F1 15,342 $7.50 $115K
Exercise Restricted Stock Units F2, F5 7,500 $0.00 $0.00
Exercise Common Stock F2 7,500 -- --
Tax Withholding Common Stock F3 3,647 $7.20 $26K
Exercise Option to Purchase Common Stock (Right to Buy) F4 34,658 $0.00 $0.00
Exercise Common Stock 34,658 $2.33 $81K
Sale Common Stock F1 34,658 $7.50 $260K
Holdings After Transaction: Restricted Stock Units — 57,292 shares (Direct); Option to Purchase Common Stock (Right to Buy) — 73,304 shares (Direct); Common Stock — 468,865 shares (Direct)
Footnotes (5)
  1. F1. Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
  2. F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
  3. F3. Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
  4. F4. The stock options are fully vested.
  5. F5. Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
Shares sold 50,000 shares Total PRECIGEN common shares sold on August 21 and 25, 2026
Sale price $7.50 per share Price for 34,658 shares on August 21, 2026 and 15,342 shares on August 25, 2026
Option exercise price $2.33 per share Exercise price for 34,658 and 15,342 option shares converted to common stock
Options exercised 50,000 shares Total PRECIGEN common shares acquired through option exercises in August 2026
RSUs converted 7,500 RSUs RSUs converting into PRECIGEN common stock on August 23, 2026
Shares withheld for taxes 3,647 shares Common shares withheld at $7.20 per share for RSU-related tax obligations
RSUs outstanding after transaction 57,292 RSUs Restricted Stock Units reported as beneficially owned following the August 23, 2026 vesting
Rule 10b5-1 trading plan regulatory
"shares sold pursuant to the terms of a 10b5-1 plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise or conversion of derivative security financial
"transaction code "M" described as Exercise or conversion of derivative security"
income tax withholding obligations financial
"shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding"
fully vested financial
"The stock options are fully vested."

FAQ

What transactions did PGEN’s COO Rutul R. Shah report in this Form 4?

Rutul R. Shah reported exercising options for 50,000 shares of PRECIGEN common stock at $2.33 per share, selling 50,000 shares at $7.50 per share under a trading plan, vesting of 7,500 RSUs, and a tax withholding of 3,647 shares.

How many PGEN shares did Rutul R. Shah sell and at what price?

Rutul R. Shah sold a total of 50,000 shares of PRECIGEN common stock, consisting of 34,658 shares on August 21, 2026 and 15,342 shares on August 25, 2026, each at a price of $7.50 per share.

Were the PGEN share sales by Rutul R. Shah made under a Rule 10b5-1 plan?

Yes. A footnote states that the reported sales of PRECIGEN common stock represent shares sold pursuant to the terms of a Rule 10b5-1 trading plan adopted by the reporting person.

What option exercises did Rutul R. Shah report for PGEN stock?

He exercised stock options to acquire 34,658 shares and 15,342 shares of PRECIGEN common stock on August 21 and 25, 2026, respectively, each with an exercise price of $2.33 per share. A footnote notes that these stock options are fully vested.

What RSU activity did PGEN disclose for Rutul R. Shah in this filing?

On August 23, 2026, 7,500 Restricted Stock Units converted into an equal number of PRECIGEN common shares. The RSUs represent part of a grant from June 26, 2025, with 1/24 of that grant vesting on that date, leaving 57,292 RSUs reported outstanding.

How many PGEN shares were withheld for taxes in connection with the RSU settlement?

The filing reports that 3,647 shares of PRECIGEN common stock were withheld by the issuer to satisfy income tax withholding obligations arising from the settlement of the vested RSUs, at a reported value of $7.20 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shah Rutul R

(Last)(First)(Middle)
20374 SENECA MEADOWS PARKWAY

(Street)
GERMANTOWN MARYLAND 20876

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/21/2026M34,658A$2.33499,670D
Common Stock08/21/2026S34,658(1)D$7.5465,012D
Common Stock08/23/2026M7,500A(2)472,512D
Common Stock08/23/2026F3,647(3)D$7.2468,865D
Common Stock08/25/2026M15,342A$2.33484,207D
Common Stock08/25/2026S15,342(1)D$7.5468,865D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock (Right to Buy)$2.3308/21/2026M34,658 (4)02/02/2032Common Stock34,658$088,646D
Restricted Stock Units(2)08/23/2026M7,500 (5) (5)Common Stock7,500$057,292D
Option to Purchase Common Stock (Right to Buy)$2.3308/25/2026M15,342 (4)02/02/2032Common Stock15,342$073,304D
Explanation of Responses:
1. Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
3. Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
4. The stock options are fully vested.
5. Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
/s/ Rutul R. Shah, by Donald P. Lehr, as attorney-in-fact08/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)